Many experimental (Kerbel & Pross, 1976; and human (Wood & Gollahon, 1977; Wood et al., 1978) tumours exhibit a significant level of macrophage (mp) infiltration and this is believed to be a manifestation of the host response (Alexander, 1976) involved in the restraint of primary tumour growth and metastatic dissemination.
Although the spontaneous regression of experimental virus-induced murine tumours has been demonstrated to be associated with alterations in the activation status of tumour-infiltrating mg (Russell & McIntosh, 1977) no such correlation has before been demonstrated in either chemicallyinduced tumours or those of spontaneous origin. However, mg isolated from non-immunogenic tumours have been demonstrated to stimulate tumour cell growth rate in vitro whilst those isolated from immunogenic tumours were cytostatic (Mantovani, 1978) . In human cancer patients a correlation has been found between the number of mp present within primary breast tumours and melanomas and extent of subsequent tumour dissemination (Gauci & Alexander, 1975) .
These data indicate that mg associated with tumours may exert anti-tumour functions under the appropriate circumstances, but generally even those tumours which contain very high levels of Macrophages, isolated from such progressively growing chemically-induced rat ) and mouse tumours (Moore & McBride, 1980) , exhibit functions which suggest that these cells are at an arrested state of differentiation such that they are not fully activated. These tumours do not generally regress spontaneously and in the present study we have used immunotherapy-induced inhibition of tumour growth as a model to investigate the role that m? may play in this process.
It has been shown previously that inhibition of tumour growth following systemic administration of Cornyebacterium parvum (C. parvum) is not associated with an increase in the numbers of tumour-infiltrating mp (Thomson et al., 1979 
Tumour
The tumour used (FSA/R) was a highly immunogenic fibrosarcoma originally induced in C3H/Buf/Kam mice by methylcholanthrene (Suit & Kastelan, 1970) . It was maintained by serial passage in syngeneic mice and the tumour was used between passage 13 and 19.
C. parvum treatment Tumours were induced in groups of 10 mice by s.c. inoculation of 5 x 105 in vivo derived tumour cells. Four days later 0.25 mg of Corynebacterium parvum (C. parvum, Burroughs Wellcome Ltd., Beckenham, Kent, England), suspended in 0.25 ml PBS was injected in the tail veins of the test group. Control mice received no treatment.
Tumour growth was monitored by taking the average of opposing diameters of tumours measured with skin calipers. Both groups of mice were monitored for up to 22 days of tumour growth and groups were killed by cervical dislocation at various intervals for tumour excision and analysis of intra-tumour host cells.
Cell fractionation
Following excision non-necrotic tumour tissue was pooled within groups and single cell suspensions prepared by enzymatic disaggregation with a mixture of Dispase/DNase as previously described (Moore & McBride, 1980) for 30 min at room temperature. After washing and resuspension 108 cells were subjected to unit gravity velocity sedimentation (Miller & Phillips, 1969) for 3 h and fractions were collected which contained cells sedimenting over the range of 1 to 14 mm h-'.
The composition of cell suspensions before and after fractionation was determined by differential counting of Jenner-Giemsa stained cytospin films prepared from cells incubated for 1 h at 37 'C with 1.1 um diam. polystyrene latex in medium containing 20% foetal calf serum (FCS).
Preparation of Macrophage monolayers 1) From non-fractionated tumour cell suspensions:
Cells were suspended at 2 x 106 ml-' in MEM containing 20% FCS and 0.05% Dispase to prevent adherence of tumour cells and the suspension prewarmed at 37°C. One-half millilitre of the cell suspension was then dispensed in pre-warmed Costor tissue culture plates (Arnold R. Horwell Ltd., London, England) and the plates incubated for 10 min before washing off the non-adherent cells x 3 with Hanks solution and finally adding 1 ml of Hanks solution before EA rosetting. These mp were denoted as rapidly adherent. 2) From fractionated tumour cell suspensions:
Cells isolated after velocity sedimentation were suspended at 5 x 105 ml-' in MEM containing 20% FCS and 0.05% Dispase. This cell suspension was treated as above but the m(p were allowed to adhere for 30min at 37°C to allow relatively less adherent mg and monocytes to attach. Both procedures gave monolayers made up of more than 85% of phagocytic mononuclear cells as determined by 1.1,um diam. polystyrene latex uptake (Moore & McBride, 1980) .
Measurement of Fc receptor avidity
Fc receptor (FcR) avidity was measured as previously described (Moore & McBride, 1980) . Briefly, aliquots of bovine erythrocytes were sensitized with doubling dilutions of hyperimmune rabbit IgG. These EA suspensions were then sedimented by centrifugation onto mg monolayers and after an incubation for 30 min at room temperature excess EA were washed off and the number of cells forming rosettes (EA RFC) was enumerated microscopically.
For each mg population the EA50 value, as a measure of FcR avidity, was calculated as follows: Figure 2a , a less marked enhancement of FcR avidity was also found in the mp sedimenting between 6 and 10mmh-' but this increase was not a consistent finding in all C. parvum-treated tumours. Macrophages sedimenting in excess of 11 mm h-' were unaffected by C. parvum therapy.
Discussion
The host cell content of immunogenic tumours undergoing C. parvum-induced growth inhibition does not differ significantly from progressor tumours growing in untreated syngeneic mice. C. parvum-induced tumour growth inhibition in this syngeneic system is however, T-cell dependent and thus one might expect some qualitative, if not a quantitative change, in those intra-tumour host cells representative of the cellular immune system. Changes in the activation state of tumour infiltrating mp have been shown to be intimately associated with regression or progression of MSV tumours (Russell et al., 1977) and in the present study we have demonstrated changes in this cell population to be associated with inhibition of growth of a chemically induced tumour following i.v. immunotherapy with C.
parvum. Measurement of the activation state of unfractionated mp isolated from regressor or progressor tumours indicated that when means of the two groups were compared a 67% increase in FcR avidity was found.
We have previously demonstrated that tumour infiltrating mononuclear phagocytes are 2 4 6 8 10 12 14 heterogeneous with respect to FcR avidity (Moore & McBride, 1980) . In that study we demonstrated the presence of two populations of mq exhibiting different activation levels of FcR and in the present study we determined which mp subpopulation was the target for C. parvum induced activation to gain some insight into how C. parvum was influencing mq differentiation within the tumour microenvironment.
When tumours from C. parvum-treated animals were subjected to fractionation by unit gravity velocity sedimentation no difference could be detected in the distribution of EA rosette forming cells when rosettes were formed using ORBC sensitised with high concentrations of antibody. However, when the mq were rosetted with ORBC sensitised with low levels of antibody, only the activated mp formed rosettes. This technique demonstrated that the smaller sized population of phagocytic cells within the tumour which sedimented at 1 to 5 mm h-exhibited the greatest increase in activation state in response to C. parvum treatment. An eight-fold increase in FcR avidity was detected within this population in contrast to a mean 67% increase in the rapidly adherent nonfractionated mp preparations. This was caused by the presence within monolayers derived from nonfractionated cells of large, rapidly sedimenting mgp which comprise 50% of the total within the tumour. These mp are unaffected by C. parvum therapy and consequently their presence results in an apparent lowering of FcR avidity when heterogeneous monolayers are examined. Although cell monolayers analysed in these experiments were routinely >85% phagocytic it has to be considered that a minor non-phagocytic cell population expressing FcR that increase in avidity after C. parvum treatment may be responsible for the observed changes. Response to C. parvum treatment in this model is T-lymphocyte dependent and tumour infiltrating T-lymphocytes may be activated simultaneously with cells of the mononuclear phagocyte series. Activated Tlymphocytes (Yoshida & Anderson, 1972) and Blymphocytes (Basten et al., 1972) express FcR which would form rosettes under the conditions used, i.e. with ORBC sensitised with high concentrations of antibody if they did contaminate the mg monolayers. It is unlikely however, that the presence of these cdontaminating lymphocytes would contribute to the FcR avidity changes observed in the monolayers isolated from the slower sedimenting lymphocyte enriched fractions. Although activation of T-lymphocytes does increase FcR expression, this level is still 10 times less than that of proteose peptone-elicited peritoneal mg (Anderson & Grey, 1974) . Earlier studies with the FSA/R tumour (Moore & McBride, 1980) indicated that the FcR avidity of the slower sedimenting tumour infiltrating mg in control animals was at least equal to that of proteose peptone-elicited mp. In the present study we are measuring increases in excess of this revel of FcR expression which eliminates the possibility of activated T-lymphocyte interference in the assay.
Results of our earlier study indicated that the intra-tumour phagocytic mononuclear cells sedimenting at the same velocity as those activated by C. parvum therapy, contain mqp which are less differentiated than the larger more rapidly 801 sedimenting cells and probably represents cells which have recently entered the tumour from the circulating monocyte pool. Systemic administration of C. parvum induces a generalised stimulation of the reticuloendothelial system (Baum & Breese, 1976) and monocytes may therefore be activated before extravasation to the solid tumour. We have previously demonstrated that full activation of m? is not achieved within the microenvironment of FSA/R tumours when growing progressively (Moore & McBride, 1980) . The activation pathway of the intra-tumour msp in C. parvum treated mice may circumvent this problem by activating the m? at a site distant to the tumour. If intra-tumour m? differentiation is normally inhibited by the high concentration of suppressor factors at the tumour site (Spitalny & North, 1977) then C. parvum induced mg activation may be occurring where these factors are at an ineffective concentration. Thus activated monocytes/macrophages may enter the tumour where they are able to exert antitumour mechanisms before being inactivated.
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